Adicet Bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Net Income	-142.66	-69.79	-62	-36.68	-28.14	-9.3	-33.78
Depreciation & Amortization	8.94	5.01	4.07	1.95	1.24	1.22	0.01
Share-Based Compensation	20.26	17.13	12.51	5.26	1.18	2.48	0.47
Other Operating Activities	19.74	2.89	-5.63	-12.09	-2.16	-12.58	22.32
Operating Cash Flow	-93.72	-44.77	-51.05	-41.55	-27.88	-18.18	-10.99
Capital Expenditures	-4.46	-16.78	-13.05	-0.99	-0.95	-0.88	-0.04
Acquisitions	0	0	0	64.11	0	0	0
Change in Investments	0	0	10.25	52.09	-46.98	-15.18	0
Investing Cash Flow	-4.46	-16.78	-2.8	115.22	-47.93	-16.06	-0.04
Share Issuance / Repurchase	0.39	45.11	242.95	0.46	0.03	0.22	0
Other Financing Activities	-0.15	-3.6	-0.26	-0.16	76.92	10.83	64.38
Financing Cash Flow	0.24	41.51	242.69	0.3	76.95	11.05	64.38
Net Cash Flow	-97.95	-20.04	188.84	73.97	1.13	-23.19	53.35
Free Cash Flow	-98.18	-61.55	-64.1	-42.54	-28.83	-19.06	-11.03
Free Cash Flow Margin	-	-246.29%	-658.77%	-237.62%	-2897.89%	-232.93%	-
Free Cash Flow Per Share	-2.28	-1.50	-2.07	-5.81	-13.48	-9.79	-19.25

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).